Member Info for krull

The MM's will play with the price, always looking for the most amount of churn

Https://youtu.be/hz45a4mrJmo

Going by the increasing month by month sales trajectory of the CiRT test, it must be selling at well over a 100 a month by now, would love to see the sales graph updated! The list price for this test is $5500, however the average sale price is $2240, I'm wondering if the price of £750 for the PSE test is negotiable also, might be that a big hospital could obtain a discount on repeated/large orders!

My reckoning, it would defy logic for this new PSA/PSE test not to make the old PSA test redundant, but I would say, the 25M PSA test numbers done annually in the US would shrink to some extent, because PSA testing is repeated due to It's inaccuracy, the PSA/PSE test will save important TIME on that front, there's also a bit of cost saving with less testing! I'm thinking a realistic 20M PSA/PSE tests at a price of $499 each year will be the new norm.

I'm sure it will, early days yet, all the rags will want to do a write up, buy now before the publicity kicks in

Yes Tricky, chunky buying hidden by the MM's, probably won't see them until the close of play.

This popped up in my YouTube home page, long winded but very informative, I didn't know women have a prostate!

The first speaker was saying: PSA screening was next to useless, 2nd said it had benefits.

This new PSA/PSE test will be in high demand.

https://youtu.be/lTjs0K-q5Is

Yes Tricky, I thought as much this morning, their was more sells than buys and the price was stable, had to be a few hidden buys propping it all up

About 52.30 minutes in: the PSE test has been compassionately used on a couple of cases, the American Oncology Network, they already know this test is coming, they are chomping at the bit, to get this test into the work up of their patients, because they know it will save money and unnecessary procedures!

Sounds Good to me.

Looks like an ALS test (motor neurone disease) will be the next one out of the traps.

PC not TC

Just been listening to the webinar again, too much info to take in all at once, around 26 minutes in: A perfect storm, the PSE test will complement the CiRT test, Doctors using the PSE test will see the value in the CiRT test. My take, in other words, where the PSE test has found advanced TC, the next step would be to look at a CiRT test to ascertain (if used) the best immunotherapy treatments

https://youtu.be/tv1zufLgtQM

Added a few more to my pot, just before whistle

Yes, buys/sells getting Harder to differentiate, I do like a Tight spread.

Yes Phimx, my understanding is, it looks at the PSA to see if it has any abnormality in it.

Also could be a big buy order getting filled

MM's accumulating stock, Iv'e noticed them do this before, just before good news arrives

The PSE test really is a game changer, It just needs a bit of publicity, then word of mouth will take over.

I also think the CiRT test is very important, It's a new tool that can help save/extend lives, sales are picking up.

My thoughts, any one with an elevated PSA test level, will be offered the PSE test, instead of the next step which is a more expensive MRI scan

It's most probable a lot of the 11p placing shares are/have been holding the share price back.

On page ten of the presentation, you can see the sales growth of the CiRT test, $2000/$2500 from that one.